The DOI matches its Crossref record.
Excess Weight Risk Factor for Alcoholic Liver Disease
Abstract
Though the hepatotoxicity of ethanol has been established, only 8% to 20% of chronic alcoholics develop cirrhosis. The aim of this study was to assess whether being overweight is a risk factor for alcoholic liver disease. One thousand six hundred four alcoholic patients were studied. According to the liver biopsies, 194 patients had a normal liver; 402 had steatosis without fibrosis; 281 presented with fibrosis, with or without steatosis; 119 presented with acute alcoholic hepatitis (AAH) without cirrhosis; 232 indicated cirrhosis without AAH; and 179 presented with cirrhosis with AAH. One hundred ninety-seven patients had clinically obvious cirrhosis. In the study, five variables were studied as risk factors: age, sex, daily consumption of alcohol during the previous 5 years, the total duration of alcohol abuse, and tendency to be overweight (body mass index [BMI] > or = 25 in women and > or = 27 in men). The BMI was calculated according to the minimum weight over the 10 previous years. In the first stepwise logistic regression analysis, age, being overweight for at least 10 years, being of the female sex, and the total duration of alcohol abuse were independently correlated with the presence of cirrhosis. In the second analysis, female sex being overweight were the two independent risk factors of AAH. In the third analysis, being overweight for at least 10 years was the only independent risk factor of steatosis. These results show that the presence of excess weight for at least 10 years is a risk factor for cirrhosis, AAH, and steatosis. Our results suggest that there is a possible potential for the metabolic effects of ethanol ingestion caused by excess weight in patients with alcoholic liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This corroborates older fi ndings of BMI as an independent risk factor for fi brosis in individuals with ALD.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [85]
Citations
Cited by
Sorted by citations
Items 501–600 of 669
Consommation chronique d’alcool et progression des lésions hépatiques
Louvet, A., & Mathurin, P. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2009.10.004 · Cited by 3
Park, J. H., Bok, M. K., Kim, J., et al. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104535 · Cited by 3
NAFLD, NASH and Orthotopic Liver Transplantation
Burke, A., & Lucey, M. R. (2004) · doi:10.1002/9780470987438.ch17 · Cited by 3
Risk factors for alcohol‐related liver disease
Kendrick, S. F. W., & Day, C. (2015) · doi:10.1002/9781118887318.ch5 · Cited by 4
Obésité et hépatopathies chroniques alcooliques et virales
Doffoël, M. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)94917-2 · Cited by 3
“Le surpoids constitue un facteur de risque indépendant à tous les stades de la maladie alcoolique du foie : stéatose, hépatite aiguë alcoolique et cirrhose, comme l’a démontré le groupe de Sylvie Naveau [8] dans une cohorte de 1 604 buveurs excessifs ayant une consommation quotidienne d’alcool ≥ 50 g dans l’année préc…”
BackgroundMusto, J., & Rice, J. P. (2025) · Clinics in Liver Disease · doi:10.1016/j.cld.2025.08.003 · Cited by 2
Histology of Liver of the Deceased Due to Harmful Use of Alcohol
Rorat, M., Hałoń, A., & Jurek, T. (2020) · Alcohol and Alcoholism · doi:10.1093/alcalc/agaa059 · Cited by 2
Hepatitis of an Unknown Etiology with Concomitant ITP
Tagliaferri, A. R., Kania, B. E., Patel, D., et al. (2023) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.55729/2000-9666.1150 · Cited by 2
Ferdouse, A., & Clugston, R. D. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15329 · Cited by 2
Paradigm shift in steatotic liver disease (SLD): from NAFLD to MASLD
Yoneda, M., Kobayashi, T., Iwaki, M., Wada, N., Nogami, A., Takahashi, H., & Nakajima, A. (2024) · Kanzo · doi:10.2957/kanzo.65.420 · Cited by 2
Immunology and treatments of fatty liver disease
Tang, S., Wu, S., Zhang, W., Ma, L., Zuo, L., & Wang, H. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03920-1 · Cited by 6
“…APOE, HFE), may determine the different responses and risks individuals face when exposed to alcohol, obesity, smoking, and viral hepatitis infection are also considered contributing factors to the development of ALD (Dam et al. 2013; Gitto et al. 2009; Naveau et al. 1997; Shoreibah et al. 2014).”
Aggravation des hépatopathies liées à l’obésité par les xénobiotiques
Fromenty, B. (2014) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2013.10.001 · Cited by 2
Liver transplantation for alcoholic hepatitis. Current situation and future
Gelu‐Siméon, M., Duclos‐Vallée, J., & Samuel, D. (2013) · Hepatology International · doi:10.1007/s12072-013-9508-2 · Cited by 2
“Concerning its prevalence, a large study using systematic biopsies in 1,604 alcoholic patients, symptomatic or not, showed the prevalence of ASH to be 20 % [3].”
BackgroundFrías, R. V., García, J. G. R., del Valle‐Laisequilla, C. F., Reyes, M. A., & Rizzoli-Córdoba, A. (2013) · Anales Médicos de la Asociación Médica del Centro Médico ABC · Cited by 2
Korean Red Ginseng Extract Suppresses the Progression of Alcoholic Fatty Liver in a Rat Model
Park, Y.-S., & Kang, J.-S. (2011) · Eisei kagaku · doi:10.1248/jhs.57.512 · Cited by 2
Épidémiologie et facteur de risque de la maladie alcoolique du foie
Lahmek, P., & Nahon, S. (2009) · EMC - Hépatologie · doi:10.1016/s1155-1976(09)40571-0 · Cited by 2
Epidemiology of Alcoholic Liver Disease
Richardson, C. T., & Singal, A. K. (2018) · Springer eBooks · doi:10.1007/978-3-319-94355-8_7 · Cited by 2
Ethanol and Hepatocarcinogenesis
Seitz, H. K., & Stickel, F. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-047-2_32 · Cited by 3
Chronic hepatitis and other liver disease
Damme, P. V., Lernout, T., Herck, K. V., Marinho, R. T., Paraná, R., & Shouval, D. (2015) · doi:10.1093/med/9780199661756.003.0216 · Cited by 2
Laswi, H., Attar, B., Abusalim, A.-R. I., Khoshbin, K., & Shaka, H. (2022) · Gastroenterology Research · doi:10.14740/gr1526 · Cited by 2
“Obesity is common in AH and associated with a greater than two-fold increase in short-term mortality [27, 28].”
BackgroundFatty Liver, NASH, and Alcoholic Liver Disease
Shimada, M., Cheng, J., & Sanyal, A. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.04207-6 · Cited by 3
Chronic hepatitis and other liver disease
Damme, P. V., Herck, K. V., Michielsen, P. P., Francque, S., & Shouval, D. (2009) · Oxford University Press eBooks · doi:10.1093/med/9780199218707.003.0073 · Cited by 2
Natural History and Cofactors of Alcoholic Liver Disease
Liangpunsakul, S., & Crabb, D. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00023-9 · Cited by 3
Optimizing therapy of liver diseases not associated with viral infection
Svistunov, A. A., Osadchuk, M. A., Kireeva, N. V., & Osadchuk, M. M. (2018) · Terapevticheskii arkhiv · doi:10.26442/terarkh2018902105-111 · Cited by 2
Bode, C., Bode, J. C., Hahn, E. G., Rossol, S., Schäfer, C., & Schuppan, D. (2002) · Springer eBooks · doi:10.1007/978-3-642-56253-2_16 · Cited by 2
Epidemiology and Risk Factors Involved in Alcoholic Liver Disease
Becker, U. (2005) · Elsevier eBooks · doi:10.1016/b978-012564370-2/50038-6 · Cited by 2
Stewart, S. F., & Day, C. (2011) · Wiley eBooks · doi:10.1002/9781444341294.ch25 · Cited by 4
Andrade, R. J., & García-Escaño, M. D. (2000) · Medicina Clínica · doi:10.1016/s0025-7753(00)71367-4 · Cited by 2
Histology of Alcohol-Related Liver Disease
Sygulla, S., & Lackner, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-32483-3_38 · Cited by 1
Difusión de nueva nomenclatura en esteatosis hepática
Aguirre, H., Pérez-Valenzuela, J., Urzúa, A. U. A., et al. (2023) · Revista Gastroenterología Latinoamericana · doi:10.46613/gastrolat2023002-06 · Cited by 1
Alcohol-associated liver disease
Singal, A. K., Mehta, H., Clemente, A. P. G., Arab, J. P., Dunn, W., & Bataller, R. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-26711-6.00028-7 · Cited by 1
Liver transplantation for alcohol-associated liver disease: The changing landscape
Yildiz, E., Zaffar, D., Öztürk, N. B., Gürakar, M., Donmez, A. E., Toruner, M. D., Şimşek, C., & Gurakar, A. O. (2025) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2024.2024.0057 · Cited by 1
“[42] A study showed that MASLD is already present in as many as 75% of individuals who are above normal weight and in more than 90% of people with high-grade obesity.”
Yang, R., Ramalingam, G., Hang, Y., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.12.031 · Cited by 1
De NAFLD a MAFLD para llegar a MASLD: La nueva nomenclatura de esteatosis hepática metabólica
Durán, D., Diego Lizama, R., Contreras, M., et al. (2025) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2025.78118 · Cited by 1
“En relación a esto, cabe destacar que se ha demostrado incluso en bebedores excesivos que la obesidad incremen-ta la prevalencia de cirrosis y la desregulación gli-cémica incrementa la severidad de la fibrosis (15,16) .”
Schult, A., Mehlig, K., Svärdsudd, K., Wallerstedt, S., Björkelund, C., Hansson, P., Zetterberg, H., & Kaczynski, J. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i6.107160 · Cited by 1
Hsieh, Y., Babuta, M., Siegenberg, H., Nagesh, P. T., Yu, Y., Tu, W., Sterling, R. K., Szabó, G., & the AlcHepNet investigators (2026) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000001066 · Cited by 1
“Obesity exacerbates the progression of ALD and increases the risk of cirrhosis (9) and liver-related mortality (8).”
InfluentialTeixeira-Clerc, F. (2015) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2014.12.002 · Cited by 1
Una Formica Nuova Italiana Spettante Ad Un Nuovo Genere.
Emery, C. (1907) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.25507 · Cited by 1
Seitz, H. K., & Mueller, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00229-4 · Cited by 2
Chapter 19Chronic Liver Disease
Said, A., & Wells, J. T. (2010) · American Public Health Association eBooks · doi:10.2105/9780875531922ch19 · Cited by 1
Pathogenic Mechanisms in Alcoholic Liver Disease (ALD): Emerging Role of Osteopontin
Coombes, J. D., & Syn, W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800773-0.00005-7 · Cited by 1
Place of Liver Transplant in Alcoholic Hepatitis
Arora, K. R. S., Sarmad, R. V. P. R., & Abrams, G. A. (2015) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.1000334 · Cited by 1
“However, most patients with AH drink more than 100 gm/d (which corresponds to six to seven alcoholic drinks per day where one drink contains 13-15 gm of alcohol, with 150-200 gm/d being common) [11,12].”
BackgroundKandari, A., Kothiyal, P., & Kumar, A. (2018) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.09686
Stewart, S. F., & Day, C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00028-0 · Cited by 3
Leptin Level and Plasma Prothrombotic Factors in Obese Subjects
Ezzat, H., El-Rahman, E. M. A., Mousa, S. G., & Mahmoud, E. A. (2006) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2006.18024 · Cited by 1
Jiménez‐Castillo, R. A., González-Martínez, C. E., Tovar-Bojorquez, E. M., Cortéz-Hernández, C. A., Jáquez-Quintana, J. O., González, J. A., González‐González, J. G., & Maldonado-Garza, H. J. (2024) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2024.502322 · Cited by 1
Esparza, A. G. P., Sánchez-Castillo, F. A., Rada-Rada, M., Noguera-Fonseca, J., Pinzón-Rodríguez, L. D., & Ávila-Espitia, T. J. (2024) · Revista Investigación en Salud Universidad de Boyacá · doi:10.24267/23897325.1037 · Cited by 1
Liver Failure from Alcohol Takes on Several Forms
Im, G. Y. (2025) · Clinics in Liver Disease · doi:10.1016/j.cld.2025.08.007 · Cited by 2
O’Gurek, D. T. (2015) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_97-1 · Cited by 2
“While the mean intake of regular alcohol to result in liver disease is approximated to be around 100 g/day for more than 20 years, [28], lesser amounts can potentially result in ALD as regular consumption of 30 g/day increases the risk for development of cirrhosis [27].”
BackgroundComment gérer les comorbidités en hépatologie ? Vers une médecine plus globale
Couzigou, P., Foucher, J., Castéra, L., & de Lédinghen, V. (2008) · La Presse Médicale · doi:10.1016/j.lpm.2007.12.011 · Cited by 1
Obstructive Sleep Apnoea: Another Burden on Cirrhotic Liver
Hussein, A. A. R. M. (2016) · Science Journal of Public Health · doi:10.11648/j.sjph.s.2016040201.11 · Cited by 1
“It was found that obesity was associated with more advanced fibrosis (14, 15) and with faster histological and/or clinical progression in longitudinal studies of patients with chronic hepatitis C (16, 17) .”
BackgroundMécanismes de l'hépatotoxicité médicamenteuse
Fromenty, B. (2010) · EMC - Hépatologie · doi:10.1016/s1155-1976(10)54650-3 · Cited by 1
A New Marker for Severity of Alcoholic Hepatitis
Calmet, F. H., & Martin, P. B. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.02.002 · Cited by 1
Current Therapeutic Strategies for Alcoholic Liver Disease
El‐Sisi, A. E., Sokar, S. S., & Mohamed, D. Z. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00002-1 · Cited by 1
Severe alcoholic hepatitis: why do we know a lot, but can do so little?
Buyeverov, A. O., Евгеньевич, С. В., & Bogomolov, P. (2018) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2018-96-5-401-410 · Cited by 1
Bernardo, S., Crespo, R. R., Saraiva, S. L., Barata, R., Gonçalves, S., Nogueira, P., Cortez‐Pinto, H., & Machado, M. V. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252218 · Cited by 1
Milani, T. Z., Zin, J. V. B., Bamberg, F. W., Mroginski, L. S. C., Corrêa, N. B., Bordignon, V. R., Zanin, G. T., Francescon, H. T., & Reichert, P. R. (2021) · Research Society and Development · doi:10.33448/rsd-v10i6.16105 · Cited by 1
Gohar, F., & Richardson, P. (2016) · In clinical practice · doi:10.1007/978-3-319-43126-0_6 · Cited by 1
Nicht-alkoholische Fettlebererkrankung und Alkoholkonsum
Stickel, F., & Datz, C. (2022) · Springer eBooks · doi:10.1007/978-3-662-62484-5_32 · Cited by 1
The Relationship Between Obesity and Alcoholic Pathology
Bunout, D. C., de la Maza, M. P., & Hirsch, S. (2005) · Elsevier eBooks · doi:10.1016/b978-012564370-2/50099-4 · Cited by 1
Danielsson, J. (2014) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Ethanol Metabolism and Pathogenesis of Alcoholic Liver Injury
Stewart, S. F., & Day, C. (2007) · doi:10.1002/9780470691861.ch12b · Cited by 1
Transient elastography for diagnosis of hepatic fibrosis in people with alcoholic liver disease
Pavlov, C. S., Casazza, G., Nikolova, D., Ivashkin, V. T., & Gluud, C. N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010542 · Cited by 1
Effect of hyperleptinaemia on chronic ethanol‐induced hepatotoxicity in mice
Vairappan, B., & Nalini, N. (2006) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00403.x · Cited by 1
Peut-on traiter la stéatohépatite métabolique ?
Ratziu, V., Vispo, M., Tahiri, M., Bonyhay, L., de Torres, M., Bernhardt, C., Poynard, T., & Lebray, P. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)89386-9 · Cited by 1
“Cependant il est actuellement reconnu que l’effet du surpoids et celui de l’alcool contribuent de façon additive à entraîner une atteinte hépatique [4-6].”
BackgroundStéatopathies hépatiques non alcooliques
Lahmek, P., & Nahon, S. (2005) · EMC - Hépato-Gastroenterologie · doi:10.1016/j.emchg.2005.01.011 · Cited by 1
RNA interference targeting leptin gene effect on hepatic stellate cells
Xiulan, X., Jusheng, L., Yuhu, S., et al. (2005) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/bf02896162 · Cited by 1
Non-alcoholic steatohepatitis: potential causes and pathogenic mechanisms
Gerbes, A., Beuers, U. H., Pape, G., Sackmann, M. F., Sauerbruch, T., & Innere, A. (2000) · Cited by 1
Hépatite alcoolique aiguë : prise en charge en 2011
Dupont, B., Dao, T., & Piquet, M. (2011) · Réanimation · doi:10.1007/s13546-011-0276-5
Does NASH or NAFLD Contribute to Comorbidity of Other Liver Diseases?
Clouston, A. D., & Powell, E. E. (2004) · doi:10.1002/9780470987438.ch23
Cofactors and alcohol‐related liver disease
O’Grady, J. G. (2015) · doi:10.1002/9781118887318.ch9
Gastrointestinal Diseases Associated with Substance Addiction
Haber, P., & Demirkol, A. (2010) · doi:10.1002/9780470710449.ch21
Escolano, E. M. R. (2008) · Institutional Repository of the University of Granada (University of Granada)
Addolorato, G., Ancona, C., Capristo, E., & Gasbarrini, A. (2005) · Elsevier eBooks · doi:10.1016/b978-012564370-2/50032-5
Susceptibility to chronic liver disease
Burza, M. A. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
THE ROLE OF FATTY ACIDS IN HUMAN ALCOHOLIC LIVER DISEASE
Naveau, S. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb04332.x
Self-citationRôle des acides gras alimentaires dans la physiopathologie des hépatopathies alcooliques
Naveau, S. (1999) · Nutrition Clinique et Métabolisme · doi:10.1016/s0985-0562(99)80048-x
Self-citationPolimorfismos genéticos en la vía de los Micro-ARN y su relación con el alcoholismo
Veleiro, I. N. (2014) · Gredos (University of Salamanca) · doi:10.14201/gredos.124189
Comment, en Afrique, gérer les comorbidités en hépatologie?
Couzigou, P. (2007) · Journal Africain d Hépato-Gastroentérologie · doi:10.1007/s12157-007-0014-9
Nichtalkoholische Leberverfettungen und Steatohepatitiden
Dancygier, H. (2003) · Springer eBooks · doi:10.1007/978-3-642-55902-0_29
Puttipittayathorn, R., Leerapun, A., Kijdamrongtham, P., et al. (2013)
Watt, K. D. S., & Sorrell, M. F. (2004) · doi:10.1007/978-1-4615-6502-4_9
Estruch, R., Sacanella, E., Fernández-Solá, J., et al. (2005) · Elsevier eBooks · doi:10.1016/b978-012564370-2/50031-3
Non-alcoholic steatohepatitis: metabolic syndrome of the liver
Day, C. P. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8767-7_17
de Oliveira, C. P. (2006) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2006.tde-31052006-150549
Retirement decisions, job loss and mortality
Zweerink, J. (2016) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Kamble, S. P., & NC DOCKS at The University of North Carolina at Charlotte (2009) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
Etiological Treatments: Lifestyle Management
Bañares, R., & Ibáñez, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-23018-4_13
Prise en charge de l'hépatite alcoolique aiguë Management of alcoholic hepatitis
Gustot, T., & Moreno, C. (2012)
Animal Models of Alcoholic Liver Disease
Xu, J., & Tsukamoto, H. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_5
Ina, K., Musso, A., Dg, B., Dobrea, G. M., Itoh, J., Yamaguchi, T., Sakai, T., Kusugami, K., Ad, L., & Fiocchi, C. (1999)
How to best diagnose NAFLD/NASH?
Ratziu, V. (2016) · doi:10.1002/9781118924938.ch13
Obesity: Treatment and Complications
Chaptini, L. A., & Peikin, S. R. (2016) · Wiley eBooks · doi:10.1002/9781118512104.ch62
生活習慣と肝臓病:診断と治療の進歩 III.アルコール性肝障害(ASH)4.治療とfollow up
眞三, 加., Yamagishi, Y., & 堀江義則 (2006) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.95.33
Acute alcoholic hepatitis: management in 2011
Dupont, B., Dao, T., & Piquet, M. (2011)
Said, A. (2016) · American Public Health Association eBooks · doi:10.2105/9780875532783ch21
Case of Bile Canalicular Antibody in a Korean Patient with Alcoholic Hepatitis
Kim, S., Jearn, L., Kim, T., et al. (2016) · Laboratory Medicine Online · doi:10.3343/lmo.2017.7.1.37
“정확한 진단과 예후판정을 위해 alcohol-non-alcohol index (ANI)가 사용 되기도 하며[13], 조직학적으로 scoring system이 개발되었고[14], 이 외에 비만도, 인슐린내성 등의 정보도 이용하고 있다[15].”
Ferri, F., Mancina, R. M., Mischitelli, M., Farcomeni, A., Poli, E., Parlati, L., Burza, M. A., Santis, A. D., Codazzo, C., Attilia, F., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31030-9
Kijdamrongthum, P., Puttipittayathorn, R., Leerapun, A., et al. (2016)
Gupta, A. (2017) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2017.09.002
“in an elegant study involving 1604 individuals showed that overweight individuals with alcoholism are more prone to develop (histologically proven) steatosis, alcoholic hepatitis and liver cirrhosis, as compared with their non-overweight counterparts.(2) In a large population based study from Finland, it was shown tha…”
Background
Metadata
- Authors
- Naveau, S., Giraud, V., Borotto, E., Aubert, A., Capron, F., & Chaput, J.
- Affiliations
- Hôpital Antoine-Béclère (FR)
- Venue
- Hepatology
- Published
- 1997-01
- Volume
- 25
- Issue
- 1
- Pages
- 108-111
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1987296974
- Cited by
- 666
- References
- 0
- Citations by year
- 2026: 4 · 2025: 19 · 2024: 27 · 2023: 40 · 2022: 19 · 2021: 21 · 2020: 27 · 2019: 22 · 2018: 41 · 2017: 29 · 2016: 36 · 2015: 45 · 2014: 37 · 2013: 21 · 2012: 27
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- alcoholic liver disease, overweight, body mass index, alcoholic cirrhosis, alcoholic hepatitis, steatosis, risk factors, sex differences, ethanol-induced hepatotoxicity
- MeSH terms
- Adult, Aged, Female, Humans, Liver Cirrhosis, Alcoholic, Male, Middle Aged, Obesity, Risk Factors, Multivariate Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review